Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:1407-1424, doi:10.1016/j.jacc.2009.04.094
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Karamitsos, T. D.
Right arrow Articles by Neubauer, S.
PubMed
Right arrow Articles by Karamitsos, T. D.
Right arrow Articles by Neubauer, S.

STATE-OF-THE-ART PAPER

The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure

Theodoros D. Karamitsos, MD, PhD*, Jane M. Francis, DCC(R), DNM*, Saul Myerson, MD*, Joseph B. Selvanayagam, MBBS, DPhil{dagger} and Stefan Neubauer, MD*,*

* University of Oxford Centre for Clinical Magnetic Resonance Research, Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom
{dagger} Department of Cardiovascular Medicine, Flinders Medical Centre, Adelaide, Australia

Manuscript received February 25, 2009; revised manuscript received April 14, 2009, accepted April 28, 2009.

* Reprint requests and correspondence: Dr. Stefan Neubauer, Department of Cardiovascular Medicine, John Radcliffe Hospital, Headley Way, Headington, OX3 9DU Oxford, United Kingdom (Email: stefan.neubauer{at}cardiov.ox.ac.uk).

Noninvasive imaging plays a central role in the diagnosis of heart failure, assessment of prognosis, and monitoring of therapy. Cardiovascular magnetic resonance (CMR) offers a comprehensive assessment of heart failure patients and is now the gold standard imaging technique to assess myocardial anatomy, regional and global function, and viability. Furthermore, it allows assessment of perfusion and acute tissue injury (edema and necrosis), whereas in nonischemic heart failure, fibrosis, infiltration, and iron overload can be detected. The information derived from CMR often reveals the underlying etiology of heart failure, and its high measurement accuracy makes it an ideal technique for monitoring disease progression and the effects of treatment. Evidence on the prognostic value of CMR-derived parameters in heart failure is rapidly emerging. This review summarizes the advantages of CMR for patients with heart failure and its important role in key areas.

Key Words: left ventricular dysfunction • heart failure • ischemia • diagnosis • therapy • prognosis • cardiovascular magnetic resonance imaging

Abbreviations and Acronyms
  ARVC = arrhythmogenic right ventricular cardiomyopathy
  CAD = coronary artery disease
  CMR = cardiovascular magnetic resonance
  CRT = cardiac resynchronization therapy
  DCM = dilated cardiomyopathy
  HCM = hypertrophic cardiomyopathy
  HF = heart failure
  LGE = late gadolinium enhancement
  LV = left ventricular
  MR = magnetic resonance
  RV = right ventricular






 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement